COSCIENS Biopharma Inc. Equity Attributable To Owners Of Parent
COSCIENS Biopharma Inc. (CSCIF) had Equity Attributable To Owners Of Parent of $3.84 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:EquityAttributableToOwnersOfParent · last filed 2026-03-25
- 2025-12-31: Equity Attributable To Owners Of Parent $3.84M.
- 2025-09-30: Equity Attributable To Owners Of Parent $5.08M.
- 2025-06-30: Equity Attributable To Owners Of Parent $7.10M.
- 2025-03-31: Equity Attributable To Owners Of Parent $10.14M.
USD
| Period end | Equity Attributable To Owners Of Parent | Equity Attributable To Owners Of Parent as first filed |
|---|---|---|
| 2025-12-31 | $3.84M 20-F · filed 2026-03-25 | |
| 2025-09-30 | $5.08M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $7.10M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $10.14M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $13.16M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $20.01M 6-K · filed 2025-11-12 | |
| 2024-06-30 | $26.23M 6-K · filed 2025-08-14 | |
| 2024-03-31 | $19.19M 6-K · filed 2025-05-13 | $12.97M 6-K · filed 2024-05-16 |
| 2023-12-31 | $21.04M 20-F · filed 2026-03-25 | $18.20M 20-F · filed 2024-03-27 |
| 2023-09-30 | $22.07M 6-K · filed 2024-11-12 | $26.28M 6-K · filed 2023-11-09 |
| 2023-06-30 | $23.37M 6-K · filed 2024-08-13 | $29.08M 6-K · filed 2023-08-09 |
| 2023-03-31 | $31.21M 6-K · filed 2024-05-16 | |
| 2022-12-31 | $23.82M 20-F · filed 2026-03-25 | $35.78M 20-F · filed 2023-03-23 |
| 2022-09-30 | $49.42M 6-K · filed 2023-11-09 | |
| 2022-06-30 | $54.29M 6-K · filed 2023-08-09 | |
| 2022-03-31 | $53.16M 6-K · filed 2023-05-09 | |
| 2021-12-31 | $21.94M 20-F · filed 2025-04-09 | $52.99M 20-F · filed 2022-03-29 |
| 2021-09-30 | $59.63M 6-K · filed 2022-11-03 | $59.93M 6-K · filed 2021-11-04 |
| 2021-06-30 | $61.35M 6-K · filed 2021-08-05 | |
| 2021-03-31 | $64.16M 6-K · filed 2022-05-11 | $64.17M 6-K · filed 2021-05-05 |
| 2020-12-31 | $13.21M 20-F/A · filed 2024-07-17 | |
| 2020-09-30 | $15.15M 6-K · filed 2021-11-04 | |
| 2020-06-30 | $931.00K 6-K · filed 2021-08-05 | |
| 2020-03-31 | $1.69M 6-K · filed 2021-05-05 | |
| 2019-12-31 | -$2.46M 20-F/A · filed 2024-02-15 | |
| 2019-09-30 | -$2.19M 6-K · filed 2020-11-05 | |
| 2019-06-30 | -$3.56M 6-K · filed 2020-11-05 | -$3.03M 6-K · filed 2019-08-13 |
| 2019-03-31 | -$3.56M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $1.91M 20-F · filed 2022-03-29 | |
| 2018-09-30 | $7.41M 6-K · filed 2019-11-07 | |
| 2018-06-30 | $9.51M 6-K · filed 2019-11-07 | |
| 2018-03-31 | $11.54M 6-K · filed 2019-08-13 | |
| 2017-12-31 | -$2.78M 20-F · filed 2020-03-31 | |
| 2016-12-31 | $6.21M 20-F · filed 2020-03-31 | |
| 2015-12-31 | $21.61M 20-F · filed 2019-04-01 | |
| 2014-12-31 | $14.48M 20-F · filed 2018-03-28 |
CAD
| Period end | Equity Attributable To Owners Of Parent |
|---|---|
| 2023-12-31 | 27.86M CAD 20-F · filed 2025-04-09 |
| 2022-12-31 | 32.29M CAD 20-F · filed 2025-04-09 |